FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W336148578> ?p ?o ?g. }

• W336148578 endingPage "899" @default.
• W336148578 startingPage "889" @default.
• W336148578 abstract "This study assessed clinical events and patient-reported chest pain 2 years after treatment of all-comers with Resolute Integrity zotarolimus-eluting stents (Medtronic Vascular, Santa Rosa, California) and Promus Element everolimus-eluting stents (Boston Scientific, Natick, Massachusetts).For both drug-eluting stents (DES), no all-comer outcome data from >12 months of follow-up have been published. Although there is increasing interest in patient-reported chest pain following stenting, data with novel DES are scarce.The DUTCH PEERS multicenter trial (TWENTE II) (DUrable Polymer-Based STent CHallenge of Promus ElemEnt Versus ReSolute Integrity) Randomized Trial [TWENTE II]) randomized 1,811 all-comer patients to treatment with 1 type of DES. Monitoring and event adjudication were performed by independent contract research organizations.The 2-year follow-up of 1,810 patients (99.9%) was available. The primary composite endpoint target vessel failure occurred in 8.6% and 7.8% of patients treated with zotarolimus- and everolimus-eluting stents, respectively (p = 0.55). Rates of components of target vessel failure were: cardiac death (2.4% vs. 1.9%, p = 0.42); target vessel-related myocardial infarction (2.4% vs. 1.8%, p = 0.33); clinically-indicated target vessel revascularization (4.6% vs. 4.9%, p = 0.83). At 1- and 2-year follow-up, >80% of patients were free from chest pain (no between-stent difference). In addition, >87% of patients were either free from chest pain or experienced pain only at maximal physical exertion, but not during normal daily activities. Patients with chest pain after 12 months at no more than moderate physical effort had a higher risk of target vessel revascularization during the following year (hazard ratio: 1.89 [95% confidence interval: 1.05 to 3.39], p = 0.03).During the second year of follow-up, the incidence of adverse clinical endpoints remained similar and low for both DES. The vast majority of patients were free from chest pain." @default.
• W336148578 created "2016-06-24" @default.
• W336148578 creator A5005157305 @default.
• W336148578 creator A5006183199 @default.
• W336148578 creator A5013170251 @default.
• W336148578 creator A5013282605 @default.
• W336148578 creator A5019960871 @default.
• W336148578 creator A5025617105 @default.
• W336148578 creator A5025633612 @default.
• W336148578 creator A5031852082 @default.
• W336148578 creator A5031934775 @default.
• W336148578 creator A5032047024 @default.
• W336148578 creator A5033855482 @default.
• W336148578 creator A5036459841 @default.
• W336148578 creator A5036599056 @default.
• W336148578 creator A5038626392 @default.
• W336148578 creator A5045476126 @default.
• W336148578 creator A5058093407 @default.
• W336148578 creator A5062318295 @default.
• W336148578 creator A5069983884 @default.
• W336148578 date "2015-06-01" @default.
• W336148578 modified "2023-10-18" @default.
• W336148578 title "Clinical Events and Patient-Reported Chest Pain in All-Comers Treated With Resolute Integrity and Promus Element Stents" @default.
• W336148578 cites W11435384 @default.
• W336148578 cites W1482348910 @default.
• W336148578 cites W1921048136 @default.
• W336148578 cites W1995110905 @default.
• W336148578 cites W2009589924 @default.
• W336148578 cites W2020906145 @default.
• W336148578 cites W2025139632 @default.
• W336148578 cites W2039425437 @default.
• W336148578 cites W2043258977 @default.
• W336148578 cites W2055057362 @default.
• W336148578 cites W2068732984 @default.
• W336148578 cites W2085920974 @default.
• W336148578 cites W2087150869 @default.
• W336148578 cites W2096913021 @default.
• W336148578 cites W2107394367 @default.
• W336148578 cites W2109647832 @default.
• W336148578 cites W2125716797 @default.
• W336148578 cites W2129834146 @default.
• W336148578 cites W2133272102 @default.
• W336148578 cites W2143566938 @default.
• W336148578 cites W2144552468 @default.
• W336148578 cites W2153614562 @default.
• W336148578 cites W2160414137 @default.
• W336148578 cites W2163397430 @default.
• W336148578 cites W2164658066 @default.
• W336148578 cites W2165282467 @default.
• W336148578 cites W2324489407 @default.
• W336148578 cites W2737117686 @default.
• W336148578 cites W8997607 @default.
• W336148578 doi "https://doi.org/10.1016/j.jcin.2015.01.033" @default.
• W336148578 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26003019" @default.
• W336148578 hasPublicationYear "2015" @default.
• W336148578 type Work @default.
• W336148578 sameAs 336148578 @default.
• W336148578 citedByCount "39" @default.
• W336148578 countsByYear W3361485782015 @default.
• W336148578 countsByYear W3361485782016 @default.
• W336148578 countsByYear W3361485782017 @default.
• W336148578 countsByYear W3361485782018 @default.
• W336148578 countsByYear W3361485782019 @default.
• W336148578 countsByYear W3361485782020 @default.
• W336148578 countsByYear W3361485782021 @default.
• W336148578 crossrefType "journal-article" @default.
• W336148578 hasAuthorship W336148578A5005157305 @default.
• W336148578 hasAuthorship W336148578A5006183199 @default.
• W336148578 hasAuthorship W336148578A5013170251 @default.
• W336148578 hasAuthorship W336148578A5013282605 @default.
• W336148578 hasAuthorship W336148578A5019960871 @default.
• W336148578 hasAuthorship W336148578A5025617105 @default.
• W336148578 hasAuthorship W336148578A5025633612 @default.
• W336148578 hasAuthorship W336148578A5031852082 @default.
• W336148578 hasAuthorship W336148578A5031934775 @default.
• W336148578 hasAuthorship W336148578A5032047024 @default.
• W336148578 hasAuthorship W336148578A5033855482 @default.
• W336148578 hasAuthorship W336148578A5036459841 @default.
• W336148578 hasAuthorship W336148578A5036599056 @default.
• W336148578 hasAuthorship W336148578A5038626392 @default.
• W336148578 hasAuthorship W336148578A5045476126 @default.
• W336148578 hasAuthorship W336148578A5058093407 @default.
• W336148578 hasAuthorship W336148578A5062318295 @default.
• W336148578 hasAuthorship W336148578A5069983884 @default.
• W336148578 hasBestOaLocation W3361485781 @default.
• W336148578 hasConcept C141071460 @default.
• W336148578 hasConcept C164705383 @default.
• W336148578 hasConcept C168563851 @default.
• W336148578 hasConcept C203092338 @default.
• W336148578 hasConcept C2777546689 @default.
• W336148578 hasConcept C2778283817 @default.
• W336148578 hasConcept C2778583881 @default.
• W336148578 hasConcept C2778704086 @default.
• W336148578 hasConcept C2780797203 @default.
• W336148578 hasConcept C500558357 @default.
• W336148578 hasConcept C71924100 @default.
• W336148578 hasConceptScore W336148578C141071460 @default.
• W336148578 hasConceptScore W336148578C164705383 @default.

• next